论文部分内容阅读
目的:探讨甘精胰岛素联合阿卡波糖治疗老年糖尿病疗效。方法:按照治疗方式的不同将2013年12月至2014年12月该院救治的112例老年糖尿病患者分为治疗组和对照组,对照组患者予以单纯甘精胰岛素治疗,治疗组患者予以阿卡波糖联合甘精胰岛素治疗,并比较两组患者治疗前后空腹状态下血糖水平(FPG)、餐后2 h血糖水平(2hPG)及糖化血红蛋白水平(HbA1c)的变化情况及临床治疗效果。结果:治疗组患者FPG、2hPG以及Hb A1c的变化情况等显著优于对照组(P<0.05);同时治疗组患者临床治疗总有效率为97.87%(52/56),对照组患者临床治疗总有效率为82.14%(46/56),两组比较差异显著(P<0.05)。结论:甘精胰岛素联合阿卡波糖在老年性糖尿病患者的治疗方面临床效果明显,可在较短时间内有效控制患者血糖水平,该方法值得在临床推广应用。
Objective: To investigate the efficacy of glargine combined with acarbose in the treatment of senile diabetes. Methods: According to the different treatment methods, 112 elderly diabetic patients who were treated in this hospital from December 2013 to December 2014 were divided into treatment group and control group. Patients in control group were treated with insulin glargine alone and patients in treatment group were treated with Acai Wave glucose combined with insulin glargine treatment before and after treatment of fasting blood glucose levels (FPG), 2 h postprandial blood glucose levels (2hPG) and glycosylated hemoglobin (HbA1c) changes and clinical treatment. Results: The changes of FPG, 2hPG and Hb A1c in the treatment group were significantly better than those in the control group (P <0.05). The total effective rate of clinical treatment in the treatment group was 97.87% (52/56) The effective rate was 82.14% (46/56), with significant difference between the two groups (P <0.05). Conclusion: Glargine and acarbose have obvious clinical effect in the treatment of senile diabetes patients and can effectively control the blood glucose level in a short period of time. This method is worthy of clinical application.